{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:44:52Z","timestamp":1792572292403,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.nucmedbio.2008.04.005","type":"journal-article","created":{"date-parts":[[2008,6,18]],"date-time":"2008-06-18T08:53:25Z","timestamp":1213779205000},"page":"725-731","source":"Crossref","is-referenced-by-count":27,"title":["Automated synthesis of the generic peptide labelling agent N-succinimidyl 4-[18F]fluorobenzoate and application to 18F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography"],"prefix":"10.1016","volume":"35","author":[{"given":"Peter","family":"Johnstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2008.04.005_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1124\/pr.57.2.5","article-title":"International Union of Pharmacology. XLVI. G protein-coupled receptor list","volume":"57","author":"Foord","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib2","first-page":"448","article-title":"Regulation of vascular reactivity by established and emerging GPCRs","volume":"26","author":"Maguire","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/45809","article-title":"Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14","volume":"401","author":"Ames","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tips.2003.12.005","article-title":"From \u2018gills to pills\u2019: urotensin-II as a regulator of mammalian cardiorenal function","volume":"25","author":"Douglas","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjp.0703601","article-title":"Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1","volume":"131","author":"Maguire","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib6","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1161\/01.CIR.0000044388.19119.02","article-title":"Plasma urotensin in human systolic heart failure","volume":"106","author":"Ng","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib7","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.peptides.2006.06.011","article-title":"Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease","volume":"27","author":"Bousette","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib8","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.peptides.2004.01.028","article-title":"Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries","volume":"25","author":"Maguire","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0883-2897(92)90111-B","article-title":"Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate","volume":"19","author":"Vaidyanathan","year":"1992","journal-title":"Int J Rad Appl Instrum B"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0969-8051(96)00017-0","article-title":"A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photochemical conjugation","volume":"23","author":"Wester","year":"1996","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib11","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/00005344-200036001-00020","article-title":"Syntheses of the first endothelin-A- and -B-selective radioligands for positron emission tomography","volume":"36","author":"Johnstr\u00f6m","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 48","key":"10.1016\/j.nucmedbio.2008.04.005_bib12","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1042\/CS103S004S","article-title":"18F-Endothelin-1, a positron emission tomography (PET) radioligand for the endothelin receptor system: radiosynthesis and in vivo imaging using microPET","volume":"103","author":"Johnstr\u00f6m","year":"2002","journal-title":"Clin Sci"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib13","first-page":"63P","article-title":"Radiosynthesis and in vivo biodistribution of [18F]-Big ET-1, a potential PET radioligand for the study of enzyme conversion of Big ET-1 to ET-1","volume":"137","author":"Johnstr\u00f6m","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bjp.0706064","article-title":"Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ETB receptors in vivo","volume":"144","author":"Johnstr\u00f6m","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3181\/00379727-231-2310736","article-title":"Imaging endothelin ETB receptors using [18F]-BQ3020: in vitro characterization and positron emission tomography (microPET)","volume":"231","author":"Johnstr\u00f6m","year":"2006","journal-title":"Exp Biol Med"},{"issue":"Suppl. 1","key":"10.1016\/j.nucmedbio.2008.04.005_bib16","doi-asserted-by":"crossref","first-page":"S1045","DOI":"10.1002\/jlcr.25804401372","article-title":"New automation of [18F]MPPF using a Coincidence synthesizer","volume":"44","author":"Le Bars","year":"2001","journal-title":"J Label Compnd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.nucmedbio.2004.01.008","article-title":"Fully automated synthesis system of 3\u2032-deoxy-3\u2032-[18F]fluorothymidine","volume":"31","author":"Oh","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.nucmedbio.2005.06.003","article-title":"Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module","volume":"32","author":"Oh","year":"2005","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.nucmedbio.2005.07.005","article-title":"New approach to fully automated synthesis of sodium [18F]fluoroacetate \u2014 a simple and fast method using a commercial synthesizer","volume":"33","author":"Sun","year":"2006","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.apradiso.2006.06.016","article-title":"The automatic production of 16\u03b1-[18F]fluoroestradiol using a conventional [18F]FDG module with a disposable cassette system","volume":"65","author":"Oh","year":"2007","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nucmedbio.2007.11.008","article-title":"Fully automated [18F]fluorocholine synthesis in the TracerLab MXFDG Coincidence synthesizer","volume":"35","author":"Kryza","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/jlcr.2580270711","article-title":"Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides: improved synthesis of [18F]GBR-13119","volume":"27","author":"Haka","year":"1989","journal-title":"J Label Compnd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib23","first-page":"203","article-title":"Imaging and characterization of radioligands for positron emission tomography using quantitative phosphor imaging autoradiography","volume":"306","author":"Johnstr\u00f6m","year":"2005","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0003-2697(80)90515-1","article-title":"Ligand: a versatile computerized approach for characterization of ligand-binding systems","volume":"107","author":"Munson","year":"1980","journal-title":"Anal Biochem"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0196-9781(92)90027-Z","article-title":"Selective labeling of \u03b1- or \u03b5-amino groups in peptides by the Bolton\u2013Hunter reagent","volume":"13","author":"Gaudriault","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.apradiso.2005.03.005","article-title":"Module-assisted synthesis of the bifunctional labelling agent N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB)","volume":"63","author":"M\u00e4ding","year":"2005","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.apradiso.2006.06.007","article-title":"Fully automated preparation of n.c.a. 4-[18F]fluorobenzoic acid and N-succinimidyl 4-[18F]fluorobenzoate using a Siemens\/CTI chemistry process control unit (CPCU)","volume":"65","author":"Marik","year":"2007","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0969-8043(02)00302-0","article-title":"Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET","volume":"58","author":"Zijlstra","year":"2003","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib29","first-page":"513","article-title":"18F- and 131I-labeling of the octadecapeptide apamin: a selective blocker of the Ca2+ dependent K+-channel. Syntheses and in-vivo evaluation in NMRI mice","volume":"37","author":"Wester","year":"1995","journal-title":"J Label Compnd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib30","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1021\/jm0111043","article-title":"Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure\u2013activity relationships and nuclear magnetic resonance studies on urotensin II","volume":"45","author":"Flohr","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib31","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1002\/1521-3773(20020816)41:16<2940::AID-ANIE2940>3.0.CO;2-M","article-title":"Structure\u2013function analysis of urotensin II and its use in the construction of a ligand\u2013receptor working model","volume":"41","author":"Kinney","year":"2002","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib32","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1021\/jm049110x","article-title":"Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists","volume":"48","author":"Lavecchia","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2008.04.005_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0969-8051(94)90161-9","article-title":"(2-[18F]Fluoropropionyl-(d)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice","volume":"21","author":"Guhlke","year":"1994","journal-title":"Nucl Med Biol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805108001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805108001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:43:42Z","timestamp":1738262622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805108001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0969805108001029"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2008.04.005","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}